During the past decade, MetroHealth Medical Center conducted 249 clinical trials. In the 10-year time frame, 249 clinical trials started and 206 clinical trials were completed, i.e. on average, 82.7% percent of trials that started reached the finish line to date. In the past 5 years, 96 clinical trials started and 101 clinical trials were completed. i.e. 105.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MetroHealth Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 119 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 76 trials sponsored, "MetroHealth Medical Center" with 69 trials sponsored, "SWOG Cancer Research Network" with 17 trials sponsored and "Gynecologic Oncology Group" with 17 trials sponsored. Other sponsors include 313 different institutions and companies that sponsored additional 164 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MetroHealth Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 79 trials as a collaborator, "NRG Oncology" with 37 trials as a collaborator, "Case Western Reserve University" with 20 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 19 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 15 trials as a collaborator. Other collaborators include 380 different institutions and companies that were collaborators in the rest 221 trials.

According to Clinical.Site data, the most researched conditions in "MetroHealth Medical Center" are "HIV Infections" (75 trials), "Stroke" (20 trials), "Heart Failure" (15 trials), "Recurrent Ovarian Carcinoma" (14 trials) and "Ovarian Endometrioid Adenocarcinoma" (13 trials). Many other conditions were trialed in "MetroHealth Medical Center" in a lesser frequency.

Most popular intervention types in "MetroHealth Medical Center" are "Drug" (376 trials), "Other" (203 trials), "Biological" (121 trials), "Procedure" (83 trials) and "Device" (59 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (78 trials), "Quality-of-Life Assessment" (59 trials), "Placebo" (55 trials), "Paclitaxel" (47 trials) and "Carboplatin" (36 trials). Other intervention names were less common.

The vast majority of trials in "MetroHealth Medical Center" are 495 trials for "All" genders, 111 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "MetroHealth Medical Center". undefined are not yet recruiting, 78 are recruiting, 109 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 335 completed trials in MetroHealth Medical Center, 5 suspended trials, and 61 terminated clinical trials to date.

Out of the total trials that were conducted in MetroHealth Medical Center, 39 "Phase 1" clinical trials were conducted, 175 "Phase 2" clinical trials and 216 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 24 trials, and there were also 127 trials that are defined as “Not Applicable".

MetroHealth Medical Center has several departments that took part in Clinical trials: "MetroHealth Cancer Care Center at MetroHealth Medical Center" - 71 trials, "MetroHealth Medical Center - Pediatric Infectious Disease" - 4 trials